Journal for ImmunoTherapy of Cancer (Aug 2021)
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
- Dimo Dietrich,
- Lutz Trojan,
- Niklas Klümper,
- Damian J Ralser,
- Romina Zarbl,
- Glen Kristiansen,
- Marieta Toma,
- Manuel Ritter,
- Michael Hölzel,
- Jörg Ellinger,
- Markus Eckstein,
- Danijel Sikic,
- Katrin Schlack,
- Andres Jan Schrader,
- Marc Rehlinghaus,
- Michèle J Hoffmann,
- Günter Niegisch,
- Annemarie Uhlig,
- Julie Steinestel,
- Konrad Steinestel,
- Ralph M Wirtz,
- Sebastian Strieth
Affiliations
- Dimo Dietrich
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Lutz Trojan
- Department of Urology, University Hospital Göttingen, Göttingen, Germany
- Niklas Klümper
- Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany
- Damian J Ralser
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Romina Zarbl
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Glen Kristiansen
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Marieta Toma
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Manuel Ritter
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Michael Hölzel
- Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany
- Jörg Ellinger
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- Markus Eckstein
- Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
- Danijel Sikic
- Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
- Katrin Schlack
- Department of Urology, University Hospital Münster, Münster, Germany
- Andres Jan Schrader
- Department of Urology, University Hospital Münster, Münster, Germany
- Marc Rehlinghaus
- Department of Urology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
- Michèle J Hoffmann
- Department of Urology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
- Günter Niegisch
- Department of Urology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
- Annemarie Uhlig
- Department of Urology, University Hospital Göttingen, Göttingen, Germany
- Julie Steinestel
- Department of Urology, University Hospital Augsburg, Augsburg, Germany
- Konrad Steinestel
- Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, Ulm, Germany
- Ralph M Wirtz
- STRATIFYER Molecular Pathology GmbH, Cologne, Germany
- Sebastian Strieth
- Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany
- DOI
- https://doi.org/10.1136/jitc-2021-002949
- Journal volume & issue
-
Vol. 9,
no. 8
Abstract
No abstracts available.